13 news items
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
presentations from experts and receiving a wide range of important clinical results for the first time. According to analysts
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
ABBV
AZN
BMY
19 Jun 24
presentations from experts and receiving a wide range of important clinical results for the first time. According to analysts
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
ABBV
11 Jun 24
the BOTOX® Cosmetic grant program in partnership with IFundWomen. The winners were hand-selected by a dedicated panel of experts
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
ABBV
CI
CVS
7 Jun 24
. over the past year, Reuters reports.
This raises concerns among drug pricing experts and analysts about the sustainability
Analyst Scoreboard: 6 Ratings For AbbVie
ABBV
5 Jun 24
Analyst Ratings: A Detailed Breakdown
A clear picture of AbbVie's perception among financial experts is painted with a thorough analysis
pdp369qgtmcsuc
ABBV
17 May 24
Ratings: An Elaborate Study
The perception of AbbVie by financial experts is analyzed through recent analyst actions. The following summary
8hpk57eqrs gry0fuw2ee678m9p
ABBV
CRBP
CRDL
14 May 24
xj5896x
ABBV
14 May 24
and oversold.
Next earnings are expected to be released in 72 days.
What The Experts Say On AbbVie
Over the past month
zx2372o5 tdq6h
ABBV
29 Apr 24
An in-depth analysis of recent analyst actions unveils how financial experts perceive AbbVie. The following summary outlines key analysts
k5jr1jb9ncwdq1pnv8pyjn m775u87351zf6i0wxdrf5xf6w
ABBV
23 Apr 24
.
Next earnings are expected to be released in 3 days.
What Analysts Are Saying About AbbVie
1 market experts have
1zt3dx2a8fjc9qq6569zuuc02iwx
ABBV
15 Apr 24
.
Next earnings report is scheduled for 11 days from now.
What Analysts Are Saying About AbbVie
2 market experts have recently
3ui3py2vgloi796
ABBV
5 Apr 24
In the last month, 2 experts released ratings on this stock with an average target price of $192.5.
An analyst from Barclays
qqk3o vi2pj
ABBV
4 Apr 24
for AbbVie
In the last month, 2 experts released ratings on this stock with an average target price of $192.5.
An analyst from
- Prev
- 1
- Next